Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ATORVASTATIN for Cardiovascular event prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 4,792 adverse event reports in the FDA FAERS database where ATORVASTATIN was used for Cardiovascular event prophylaxis.

Most Reported Side Effects for ATORVASTATIN

Side Effect Reports % Deaths Hosp.
Type 2 diabetes mellitus 7,556 9.5% 84 166
Myalgia 7,155 9.0% 233 1,230
Drug hypersensitivity 3,929 4.9% 8 147
Drug ineffective 3,865 4.9% 80 1,134
Fatigue 3,439 4.3% 237 1,096
Arthralgia 3,338 4.2% 239 642
Rhabdomyolysis 3,286 4.1% 330 2,298
Dyspnoea 3,137 3.9% 313 1,516
Nausea 2,888 3.6% 237 1,298
Asthenia 2,791 3.5% 291 1,200
Headache 2,747 3.5% 228 940
Pain 2,700 3.4% 20 1,000
Malaise 2,614 3.3% 222 1,261
Muscle spasms 2,581 3.3% 12 408
Pain in extremity 2,522 3.2% 23 637

Other Indications for ATORVASTATIN

Product used for unknown indication (22,764) Blood cholesterol increased (10,139) Hypercholesterolaemia (5,615) Dyslipidaemia (4,796) Low density lipoprotein increased (4,713) Hyperlipidaemia (3,648) Blood cholesterol abnormal (2,024) Blood cholesterol (1,722) Blood triglycerides increased (1,638) Prophylaxis (1,253)

Other Drugs Used for Cardiovascular event prophylaxis

LIPITOR (1,863) ASPIRIN (950) ASPIRIN DL-LYSINE (653) CANAKINUMAB (560) RIVAROXABAN (432) CLOPIDOGREL BISULFATE (414) TICAGRELOR (351) SEMAGLUTIDE (207) ICOSAPENT ETHYL (196) ROSUVASTATIN (156)

Related Pages

ATORVASTATIN Full Profile All Cardiovascular event prophylaxis Drugs ATORVASTATIN Demographics ATORVASTATIN Timeline